Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 24;67(1):e0220121.
doi: 10.1128/aac.02201-21. Epub 2022 Dec 19.

Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia

Affiliations

Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia

M Trang et al. Antimicrob Agents Chemother. .
No abstract available

Keywords: community-acquired bacterial pneumonia; omadacycline; pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare a conflict of interest. M.T., M.C.S., J.P.H., S.M.B., and C.M.R. are employees of the Institute for Clinical Pharmacodynamics, Inc., which has received research support from Paratek Pharmaceuticals, Inc. E.A.L. was an employee of ICPD at the time the analyses were performed and is now and employee of Vertex Pharmaceuticals, Inc. L.F. was an employee of Paratek Pharmaceuticals, Inc., at the time the analyses were performed and is now an employee of AN2 Therapeutics. J.N.S. was an employee of Paratek Pharmaceuticals, Inc., at the time the analyses were performed and is now an employee of Scientific and Medical Affairs Consulting, LLC. P.C.M. was an employee of Paratek Pharmaceuticals, Inc., at the time the analyses were performed and is now an employee of VenatoRx, Inc., and E.T. was an employee of Paratek Pharmaceuticals, Inc., at the time the analyses were performed and is now an employee of Neuraptive Therapeutics, Inc.

Figures

FIG 1
FIG 1
Box-and-whisker plot showing the distribution of day 1 omadacycline total-drug plasma AUC0–24, stratified by sex and each PORT risk class and CURB-65 score. The upper and lower edges of each box represent the 25th and 75th percentiles of the distribution of total-drug plasma AUC0–24, respectively. The line within each box represents the median total-drug plasma AUC0–24 value. The upper and lower whiskers extend to the furthest observed values within 1.5 × IQR of the respective box edges (where IQR is defined as the difference between the 25th and 75th percentiles).

References

    1. Paratek Pharmaceuticals, Inc. 2021. Nuzyra (omadacycline) package insert. Paratek Pharmaceuticals, Inc., Boston, MA.
    1. Stets R, Popescu M, Gonong JR, Mitha I, Nseir W, Madej A, Kirsch C, Das AF, Garrity-Ryan L, Steenbergen JN, Manley A, Eckburg PB, Tzanis E, McGovern PC, Loh E. 2019. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med 380:517–527. 10.1056/NEJMoa1800201. - DOI - PubMed
    1. Paratek Pharmaceuticals. 2018. Omadacycline p-toluenesulfonate tablets and injection for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). Briefing document for the Antimicrobial Drugs Advisory Committee (AMDAC). https://www.fda.gov/media/115100/download. Accessed 26 September 2022.
    1. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250. 10.1056/NEJM199701233360402. - DOI - PubMed
    1. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. 2003. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382. 10.1136/thorax.58.5.377. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources